Defilade Capital Management, L.P.

EMERYVILLE, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$598.8M2026 Q3
Positions30
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.54.9%

Defilade Capital Management, L.P. reported 30 positions worth $598.8M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: PFE (7.3%). Biggest move: reduce VEEV ($47.8M).

10 / 30 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 PFEPfizer$43.5M7.26%1,524,999——+1.2%
▸ 2 LLYEli Lilly$40.2M6.72%34,774——+23.7%
▸ 3 BMRNBiomarin Pharmaceutical$36.1M6.03%601,922——-3.3%
▸ 4 GILDGilead Sciences$33.8M5.64%226,572——+12.4%
▸ 5 AXSMAxsome Therapeutics$32.3M5.40%175,371——-25.7%
▸ 6 AMGNAmgen$31.2M5.21%74,079——+9.7%
▸ 7 ORICOric Pharmaceuticals$30.6M5.11%2,272,497——-44.2%
▸ 8 ASNDAscendis Pharma A/S$29.4M4.90%128,858——+20.9%
▸ 9 ISRGIntuitive Surgical$29.2M4.88%71,860——+7.7%
▸ 10 SYKStryker$22.5M3.75%81,524——+12.8%

Pro Feature

The remaining 20 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Defilade Capital Management, L.P. hold as of Q3 2026?

Defilade Capital Management, L.P. reported 30 positions worth $598.8M in its Q3 2026 13F filing. Largest positions: PFE (7.3%), LLY (6.7%), BMRN (6.0%), GILD (5.6%) and AXSM (5.4%).

What did Defilade Capital Management, L.P. buy in Q3 2026?

New positions: GILD, AXSM, AMGN, ISRG and SYK (8 in all). Added to: ORIC, ASND, COGT, OCUL and EVMN (9 in all).

What did Defilade Capital Management, L.P. sell in Q3 2026?

Reduced: VEEV, TMO, SOLV, ICUI and PFE (11 in all). Sold out entirely: PTCT, BAX, INSM, ZBH and PODD (17 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.